Home » Canada Approves DermTech Pigmented Lesions Assay
Canada Approves DermTech Pigmented Lesions Assay
California-based manufacturer of molecular dermatology DermTech secured approval to market its Pigmented Lesions Assay and its biopsy kit for detecting melanoma in Canada.
DermTech Canada will market and sell the assay in the country, and biopsy samples will be processed at the company’s central laboratory in La Jolla.
The assay is designed to analyze skin biopsy samples through a noninvasive adhesive patch.
Upcoming Events
-
21Oct